These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Understanding the elements of overactive bladder: questions raised by the EPIC study. Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K, EPIC Study Group. BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602 [Abstract] [Full Text] [Related]
4. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. Sexton CC, Coyne KS, Kopp ZS, Irwin DE, Milsom I, Aiyer LP, Tubaro A, Chapple CR, Wein AJ, EpiLUTS Team. BJU Int; 2009 Apr; 103 Suppl 3():12-23. PubMed ID: 19302498 [Abstract] [Full Text] [Related]
12. A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey. Herschorn S, Gajewski J, Schulz J, Corcos J. BJU Int; 2008 Jan; 101(1):52-8. PubMed ID: 17908260 [Abstract] [Full Text] [Related]
13. Symptom bother and health care-seeking behavior among individuals with overactive bladder. Irwin DE, Milsom I, Kopp Z, Abrams P, EPIC Study Group. Eur Urol; 2008 May; 53(5):1029-37. PubMed ID: 18243515 [Abstract] [Full Text] [Related]
14. Examining lower urinary tract symptom constellations using cluster analysis. Coyne KS, Matza LS, Kopp ZS, Thompson C, Henry D, Irwin DE, Artibani W, Herschorn S, Milsom I. BJU Int; 2008 May; 101(10):1267-73. PubMed ID: 18336611 [Abstract] [Full Text] [Related]
15. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms. Kaplan SA, Roehrborn CG, Gong J, Sun F, Guan Z. BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995 [Abstract] [Full Text] [Related]